AI and Benefit Verification: Providing Faster Access to Medicines
Pharmaceutical Executive |
The benefit verification (BV) process helps patients gain access to the therapies they need. Technology enables the BV process to become more efficient—improving speed and scale, without compromising the quality of the results or further delaying patient treatment.
In a recent Pharmaceutical Executive article, Amy Jones, Director, Product Strategy e-Technologies at Lash Group, discusses how Lash Group’s eBV solution leverages data and artificial intelligence to drive quicker patient access to medications.